chr15-53615520-G-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_182758.4(WDR72):c.2686C>T(p.Arg896*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,612,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000089 ( 0 hom. )
Consequence
WDR72
NM_182758.4 stop_gained
NM_182758.4 stop_gained
Scores
2
2
3
Clinical Significance
Conservation
PhyloP100: 2.54
Genes affected
WDR72 (HGNC:26790): (WD repeat domain 72) This gene encodes a protein with eight WD-40 repeats. Mutations in this gene have been associated with amelogenesis imperfecta hypomaturation type 2A3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-53615520-G-A is Pathogenic according to our data. Variant chr15-53615520-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 522610.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR72 | NM_182758.4 | c.2686C>T | p.Arg896* | stop_gained | 15/20 | ENST00000360509.10 | NP_877435.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR72 | ENST00000360509.10 | c.2686C>T | p.Arg896* | stop_gained | 15/20 | 1 | NM_182758.4 | ENSP00000353699.5 | ||
WDR72 | ENST00000396328.5 | c.2686C>T | p.Arg896* | stop_gained | 15/20 | 1 | ENSP00000379619.1 | |||
WDR72 | ENST00000559418.5 | c.2716C>T | p.Arg906* | stop_gained | 14/19 | 5 | ENSP00000452765.1 | |||
WDR72 | ENST00000557913.5 | c.2677C>T | p.Arg893* | stop_gained | 15/20 | 5 | ENSP00000453378.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151826Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
151826
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249874Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135200
GnomAD3 exomes
AF:
AC:
6
AN:
249874
Hom.:
AF XY:
AC XY:
3
AN XY:
135200
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000890 AC: 13AN: 1460602Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726626
GnomAD4 exome
AF:
AC:
13
AN:
1460602
Hom.:
Cov.:
31
AF XY:
AC XY:
9
AN XY:
726626
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151944Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74290
GnomAD4 genome
AF:
AC:
2
AN:
151944
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74290
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Amelogenesis imperfecta hypomaturation type 2A3 Pathogenic:2
Pathogenic, no assertion criteria provided | research | Institute of Human Genetics, University of Ulm | Apr 18, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 03, 2022 | - - |
Amelogenesis imperfecta hypomaturation type 2A3;C5436235:Renal tubular acidosis, distal, 4, with hemolytic anemia Pathogenic:1
Pathogenic, no assertion criteria provided | research | Division of Molecular Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University | Jan 01, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Benign
FATHMM_MKL
Benign
N
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at